Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.64 |
| ▸ | MAPT | P10636 | 4/20 | 0.63 |
| ▸ | LMNA | P02545 | 3/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.63 |
| ▸ | KCNA5 | P22460 | 2/20 | 0.56 |
| ▸ | GAA | P10253 | 3/20 | 0.55 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | ITGB3 | P05106 | 2/20 | 0.55 |
| ▸ | ITGA2B | P08514 | 2/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.53 |
| ▸ | THRB | P10828 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7813988 | 0.82 | L3MBTL1 (0.58) | L3MBTL1MAPTLMNAALDH1A1KCNA5 | |
| SCHEMBL9011266 | 0.81 | ALDH1A1 (0.57) | L3MBTL1MAPTLMNAALDH1A1KCNA5 | |
| SCHEMBL7811910 | 0.81 | L3MBTL1 (0.57) | L3MBTL1MAPTLMNAALDH1A1KCNA5 | |
| SCHEMBL7814104 | 0.80 | KCNA5 (0.58) | L3MBTL1MAPTLMNAALDH1A1KCNA5 | |
| SCHEMBL27303876 | 0.79 | MAPT (0.64) | L3MBTL1MAPTLMNAALDH1A1KCNA5 | |
| SCHEMBL7811474 | 0.77 | MAPT (0.65) | L3MBTL1MAPTLMNAALDH1A1GAA | |
| SCHEMBL7814235 | 0.77 | LMNA (0.71) | MAPTLMNAALDH1A1GAAKMT2A | |
| SCHEMBL7817566 | 0.77 | MAPT (0.55) | L3MBTL1MAPTLMNAALDH1A1KCNA5 | |
| SCHEMBL7817516 | 0.77 | L3MBTL1 (0.69) | L3MBTL1MAPTLMNAALDH1A1KCNA5 | |
| SCHEMBL7813835 | 0.76 | ALDH1A1 (0.57) | MAPTLMNAALDH1A1KMT2AITGB3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0607536-B1 | Arylamide derivatives | SS PHARMACEUTICAL CO (JP) | 2001-01-24 | — | — | EP | disclosed |
| US-5532371-A | SIDE EFFECT REDUCTION | SS PHARMACEUTICAL CO., LTD. (JP) | 1996-07-02 | — | — | US | disclosed |
| US-5411972-A | Arylamide derivatives for treating hyperlipemia | SS PHARMACEUTICAL CO., LTD. (JP) | 1995-05-02 | — | — | US | disclosed |
| EP-0607536-A1 | Arylamide derivatives | SS PHARMACEUTICAL CO., LTD. (JP) | 1994-07-27 | — | — | EP | disclosed |